title: The ACVD task force on canine atopic dermatitis (XX): glucocorticoid pharmacotherapy.
abstract: Glucocorticoids (GCs) have been the most commonly prescribed drugs for treatment of canine atopic dermatitis (AD) during the last decades. In spite of this widespread usage, there are a few studies documenting their efficacy. Fortunately, recently completed clinical trials were designed with oral GCs used as "standard of care" for treatment of canine AD. These studies provided high quality evidence in favor of the strong efficacy of oral low-dose glucocorticoid formulations to control skin lesions and pruritus in dogs with AD. Consequently, there is good evidence to support the recommendation of use of oral glucocorticoids for treatment of canine AD.
authors.affiliation: Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough Street, Raleigh, NC 27606, USA. thierry_olivry@ncsu.edu
authors.forename: T
authors.initials: T
authors.lastname: Olivry
authors.forename: C A
authors.initials: CA
authors.lastname: Sousa
mesh_terms: D000284:Administration, Oral; D000287:Administration, Topical; D000818:Animals; D002986:Clinical Trials as Topic / Q000662:veterinary; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000662:veterinary*; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D012955:Societies, Medical; D014481:United States
chemical_list: D005938:Glucocorticoids